liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Potential Muscle Biomarkers of Chronic Myalgia in Humans - A Systematic Review of Microdialysis Studies
Linköping University, Department of Medical and Health Sciences, Rehabilitation Medicine. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Anaesthetics, Operations and Specialty Surgery Center, Pain and Rehabilitation Center.
Linköping University, Department of Medical and Health Sciences, Rehabilitation Medicine. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Anaesthetics, Operations and Specialty Surgery Center, Pain and Rehabilitation Center.
2012 (English)In: Biomarker / [ed] Tapan Kumar Khan, INTECH, 2012, 102-132 p.Chapter in book (Other academic)
Abstract [en]

The impact of biomarkers in present day health care system, health management and healthy life is enormous. Clinicians need them for diagnosis, prognosis, effect of therapeutic intervention, and most importantly, for early detection of a disease. Pharmaceutical industries need them for new drug discovery and drug efficiency test. Regulatory authorities need them for testing toxicity and environmental impact. Epidemiologists need them for population screening and risk factor determination. In post genomic era biomarkers would have a huge impact in personalized medicine and personalized health management. This scope of this book is not limited to just a few of the most important aspects of biomarkers but covers wide variety of subjects, from biomarkers cancer to neurodegenerative diseases. Chapters cover variety of aspects, from modern cell based technologies to molecular imaging; from drug discovery to critical care prognosis. A great amount of information is also devoted to bioinformatics and statistics. There is an enormous potential for commercial value of biomarkers. The global diagnostic market accounts for only 1-2% of government healthcare expense, however, it influences on 60-70% decisions in healthcare. My sincere thanks go to all the contributors of this book who took the extra effort beyond their busy schedules. Last, but not least I would like to express my gratitude to the publishing group for their tireless support

Place, publisher, year, edition, pages
INTECH, 2012. 102-132 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-79966DOI: 10.5772/38822ISBN: 978-953-51-0577-0 (print)OAI: oai:DiVA.org:liu-79966DiVA: diva2:544877
Available from: 2012-08-16 Created: 2012-08-16 Last updated: 2014-11-19Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textfind book in another country/hitta boken i ett annat landhttp://text.123doc.vn/document/1265038-biomarker-edited-by-tapan-kumar-khan-doc.htm

Authority records BETA

Gerdle, BjörnLarsson, Britt

Search in DiVA

By author/editor
Gerdle, BjörnLarsson, Britt
By organisation
Rehabilitation MedicineFaculty of Health SciencesPain and Rehabilitation Center
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
isbn
urn-nbn

Altmetric score

doi
isbn
urn-nbn
Total: 200 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf